Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

  • Lisa M McShane1Email author,
  • Margaret M Cavenagh2,
  • Tracy G Lively3,
  • David A Eberhard4,
  • William L Bigbee5,
  • P Mickey Williams6,
  • Jill P Mesirov7,
  • Mei-Yin C Polley8,
  • Kelly Y Kim9,
  • James V Tricoli10,
  • Jeremy MG Taylor11,
  • Deborah J Shuman12,
  • Richard M Simon13,
  • James H Doroshow12 and
  • Barbara A Conley14
BMC Medicine201311:220

DOI: 10.1186/1741-7015-11-220

Received: 28 May 2013

Accepted: 6 August 2013

Published: 17 October 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 May 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
17 Jun 2013 Reviewed Reviewer Report - Nathan Price
25 Jun 2013 Reviewed Reviewer Report - David Parkinson
2 Aug 2013 Author responded Author comments - Lisa McShane
Resubmission - Version 3
2 Aug 2013 Submitted Manuscript version 3
Publishing
6 Aug 2013 Editorially accepted
17 Oct 2013 Article published 10.1186/1741-7015-11-220

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(2)
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(3)
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(4)
Department of Pathology and Lineberger Comprehensive Cancer Center, University of North Carolina
(5)
Department of Pathology, and University of Pittsburgh Cancer Institute, Hillman Cancer Center, UPCI Research Pavilion
(6)
Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health
(7)
Computational Biology and Bioinformatics, Broad Institute of Massachusetts Institute of Technology and Harvard University, 7 Cambridge Center
(8)
Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(9)
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(10)
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(11)
Department of Biostatistics, University of Michigan
(12)
Office of the Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(13)
Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health
(14)
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health

Advertisement